Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $17.8200 (-1.27%) ($17.7300 - $18.0800) on Tue. Jan. 7, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.12% (three month average) | RSI | 30 | Latest Price | $17.8200(-1.27%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | HALO declines -1.9% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(54%) IWO(54%) IWM(50%) IWC(49%) XBI(49%) | Factors Impacting HALO price | HALO will decline at least -1.06% in a week (0% probabilities). VIXM(-38%) VXX(-20%) UUP(-7%) TLT(-3%) SHY(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.06% (StdDev 2.12%) | Hourly BBV | 0 () | Intraday Trend | -0.7% | | | |
|
1 - 5 Day Possible Target | $13.19(-25.98%) | Resistance Level | $18.38 | 5 Day Moving Average | $17.89(-0.39%) | 10 Day Moving Average | $18.03(-1.16%) | 20 Day Moving Average | $18.38(-3.05%) | To recent high | -8.8% | To recent low | 19.4% | Market Cap | $2.435b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |